Translation of Stroke Specific Quality of Life Questionnaire Into Local Languages of Pakistan
30. marts 2022 opdateret af: Riphah International University
Reliability and Validity of Stroke Specific Quality of Life Scale in Local Languages of Pakistan
The aim of the present study is to translate the Stroke Specific Quality of Life Questionnaire into local languages of Pakistan along with validation of the translated versions by evaluating their validity and reliability in the people of Pakistan, speaking respective languages and suffering from a stroke.
No such study has been previously conducted in the Pakistan region which translates the specific questionnaire and follows the proper cross-culture adaptation protocol.
Studieoversigt
Status
Rekruttering
Betingelser
Detaljeret beskrivelse
The stroke-Specific Quality of Life Scale is regarded as one of the most extensive and more commonly utilized patient-centred and self-reported measure of outcomes in the stroke population. The SS-QoL scale is a health-related outcome measure that comprises 49 items in 12 areas of vision, mobility, thinking, social roles, self-care, language, personality, family roles, work/productivity, upper limb function, mood and energy. It covers a more extensive inclusion of capacities ordinarily influenced by stroke.
The Stroke Specific Quality of Life questionnaire, originally developed in English, has been translated into many languages to assess for its validity and reliability ever since, but not any of the Pakistani native versions are made or tested. Previous studies have shown that the translation of the scale would end up giving a standard measure to be utilized in clinical practices and research studies while sanctioning clinicians and specialists to share information and have an insight into patient's health-related concerns post-stroke. Thus, it is imperative to translate this questionnaire into psychometrically sound versions of indigenous Pakistani languages such as Urdu, Punjabi, Sindhi, Balochi and Pashto. This may promote an easy understanding of the local population in Pakistan where the languages are spoken and will provide a valid measure of stroke-specific health outcomes to be clinically utilized by practitioners and researchers across the country.
Undersøgelsestype
Observationel
Tilmelding (Forventet)
1125
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Ayesha Javed, MSPT(NMPT*)
- Telefonnummer: 03165278975
- E-mail: ayesha11492@gmail.com
Studiesteder
-
-
KPK
-
Abbottabad, KPK, Pakistan, 22010
- Rekruttering
- Physiotherapy Department WIRS
-
Kontakt:
- Umber Fatima, M.Phil
- Telefonnummer: 03314721691
- E-mail: umber.fatima11@gmail.com
-
Ledende efterforsker:
- Ayesha Javed, MSPT(NMPT*)
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
40 år til 70 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
To meet inclusion criteria, participants diagnosed with stroke (sub-acute/chronic stage), clinically stable, between age 40-70 years and able to read and complete the local language version of SSQoL.
Then patient response will be checked on the translated versions.
Beskrivelse
Inclusion Criteria:
- Patients post-stroke (sub-acute/chronic stage)
- Participants belonging to Urdu, Punjabi, Sindhi, Balochi and Pashto speaking class
- Patients should be capable to complete the questionnaire without any help.
Exclusion Criteria:
- Healthy population
- Patients at the acute stage of stroke/ TIA.
- Individuals diagnosed with conditions other than stroke.
- Individuals with language/ memory problems.
- Individuals with disability due to any structural/congenital cause.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Cross-Cultural Translation of Stroke Specific Quality of Life Scale into local languages of Pakistan
Tidsramme: 6 months
|
The Stroke Specific Quality of Life Scale (SSQoL) is regarded as one of the most extensive and more commonly utilized patient-centred and self-reported measure of outcomes in the stroke population.
It is a health-related stroke outcome measure intended to gather all the relevant concerns significant to the stroke population.
The responses are obtained via a progression of a series of centred meetings and interviews with concerned post-stroke patients to survey personal satisfaction.
The SS-QoL comprises 49 items in 12 areas of vision, mobility, thinking, social roles, self-care, language, personality, family roles, work/productivity, upper limb function, mood and energy.
The patient responses are appraised on a Likert scale consisting of 5 points with greater scores demonstrating better capacity.
It covers a more extensive inclusion of capacities ordinarily influenced by stroke.
Its translation is to be done in the local languages of Pakistan through a rigorous and approved process.
|
6 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Reliability and Validity of translated versions
Tidsramme: 6 months
|
To determine reliability and validity of cross-culturally adapted and the translated versions of SSQoL in stroke patients with respective languages.
Reliability or reproducibility refers to the ability of a measure to produce the same results when administered at two or more interval between different visits of the patient and validity is how accurate the tool measures an item it is supposed to.
Thus these both are to measured through various parameters to validate the translated versions as appropriate and applicable.
|
6 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HC. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010 May;19(4):539-49. doi: 10.1007/s11136-010-9606-8. Epub 2010 Feb 19.
- Williams LS, Weinberger M, Harris LE, Clark DO, Biller J. Development of a stroke-specific quality of life scale. Stroke. 1999 Jul;30(7):1362-9. doi: 10.1161/01.str.30.7.1362.
- Ganvir S, Harishch M, Kunde C. Validation of Marathi Version of Stroke-specific Quality of Life. Ann Indian Acad Neurol. 2018 Oct-Dec;21(4):290-293. doi: 10.4103/aian.AIAN_449_17.
- Sallam SA, Al-Khamis FA, Muaidi QI, Abdulla FA. Translation and validation of the stroke specific quality of life scale into Arabic. NeuroRehabilitation. 2019;44(2):283-293. doi: 10.3233/NRE-182552.
- Mahmoodi M, Safari A, Vossoughi M, Golbon-Haghighi F, Kamali-Sarvestani M, Ghaem H, Borhani-Haghighi A. Stroke specific quality of life questionnaire: Test of reliability and validity of the Persian version. Iran J Neurol. 2015 Apr 4;14(2):94-100.
- Lo SH, Chang AM, Chau JP. Establishing equivalence of a Chinese version of the stroke specific quality of life measure for stroke survivors. Disabil Rehabil. 2017 Jun;39(11):1079-1086. doi: 10.1080/09638288.2016.1178348. Epub 2016 May 23.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
10. marts 2021
Primær færdiggørelse (Forventet)
22. april 2022
Studieafslutning (Forventet)
30. april 2022
Datoer for studieregistrering
Først indsendt
8. april 2021
Først indsendt, der opfyldte QC-kriterier
12. april 2021
Først opslået (Faktiske)
13. april 2021
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
31. marts 2022
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
30. marts 2022
Sidst verificeret
1. marts 2022
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- REC/00960 Ayesha Javed
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .